Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04820764 · ClinicalTrials.gov registry record · NA
EFS of the CardioMech MVRS
A NA study of Mitral Regurgitation, sponsored by CardioMech AS.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 12
- Study locations
NCT04820764: Recruiting NA study of Mitral Regurgitation, sponsored by CardioMech AS.
NCT04820764 is a NA study of Mitral Regurgitation that is actively recruiting participants, run by CardioMech AS. The registered enrollment target is 25 participants, below the 1,023-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (98% lower). The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04820764, a NA study of Mitral Regurgitation, is actively recruiting participants, sponsored by CardioMech AS.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 12
- Study locations
Study Summary
Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
Conditions Studied
Interventions
- DEVICE CardioMech MVRS
Study Locations (12)
Minnesota
- Mayo Clinic - Rochester
- CentraCare Heart & Vascular Center - Saint Cloud
Ohio
- The Christ Hospital - Cincinnati
- Cleveland Clinic - Cleveland
California
- Cardiovascular Institute of Los Robles Health System - Thousand Oaks
Illinois
- Northwestern University - Evanston
Kansas
- Ascension St. Francis via Christi - Wichita
New York
- NYU Langone - New York
North Carolina
- Atrium Health Sanger Heart and Vascular Institute - Charlotte
Tennessee
- Ascension St. Thomas West - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-07-27 |
| Est. Completion | 2031-09 |
| Phase | NA |
What NCT04820764 shows while recruiting
NCT04820764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,023-participant average among 26 other Mitral Regurgitation trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Mitral Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which CardioMech MVRS is the first listed.
NCT04820764 lists 12 locations in 10 states (Minnesota, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT04820764 about?
NCT04820764 is a clinical study titled "EFS of the CardioMech MVRS". Safety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
What is the current status of trial NCT04820764?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2021-07-27. Estimated completion is 2031-09.
What conditions does trial NCT04820764 study?
This clinical trial studies the following conditions: Mitral Regurgitation.
What interventions are being tested in trial NCT04820764?
The interventions under investigation include: CardioMech MVRS (DEVICE).
Who is sponsoring clinical trial NCT04820764?
This trial is sponsored by CardioMech AS, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04820764 being conducted?
This trial has 12 study locations across California, Illinois, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04820764's enrollment target sits among peer trials
25 23rd of 26 higher than 2 of 26 other Mitral Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mitral Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
RECRUITING · NA
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
RECRUITING · NA
-
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
RECRUITING · NA
-
Cephea Early Feasibility Study
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
The CardioClip Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI